Biotech Stock in Focus: Abbvie Q2 Earnings Impress Due to Humira Sales

AbbVie Inc (ABBV) reported second quarter 2014 earnings of 82 cents per share, unchanged from the year-ago earnings but surpassing the Consensus Estimate of 76 cents. Revenues increased 5% to $4.926 billion in the second quarter of 2014, surpassing the Consensus Estimate of $4.671 billion. Results were boosted by Humira’s strong performance. Including one-time items,…

Read More

Worth Watching Stocks : General Electric Company (NYSE:GE), Home Depot (NYSE:HD), Powell Industries (NASDAQ:POWL), Delcath (NASDAQ:DCTH), Verisk Analytics (NASDAQ:VRSK)

General Electric Company (NYSE:GE), which already has a formidable presence in Africa, said on Monday it was planning $US2 billion in new investments to build and assemble equipment for oil and other industries, as well as training in health and other sectors. General Electric Company (NYSE:GE) belongs to Industrial Goods sector. Its net profit margin…

Read More
Home